SCHEMBL5794717

SCHEMBL5794717

CCn1c2c(c3c(OC)c(C(=O)OC)cc(Cl)c31)CCCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GALK1 P51570 1/20 0.39
▸ FABP4 P15090 4/20 0.36
▸ HSD17B10 Q99714 4/20 0.36
▸ HPGD P15428 3/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ GAA P10253 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ DRD2 P14416 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ DRD1 P21728 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ DRD5 P21918 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4023327 0.74 HSD17B10 (0.41) FABP4HSD17B10HPGDKDM4EALDH1A1
SCHEMBL4024437 0.74 HSD17B10 (0.46) FABP4HSD17B10HPGDKDM4EALDH1A1
SCHEMBL6691286 0.71 FABP4 (0.61) FABP4
SCHEMBL5794726 0.68 ALDH1A1 (0.39) FABP4HSD17B10HPGDKDM4EALDH1A1
SCHEMBL7415790 0.65 PARP1 (0.43) GALK1HSD17B10HPGDKDM4EALDH1A1
SCHEMBL7122377 0.65 FABP4 (0.51) FABP4HPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL7176265 0.65 CNR1 (0.43) FABP4HSD17B10KDM4EALDH1A1KMT2A
SCHEMBL4029927 0.64 SCARB1 (0.43) FABP4HSD17B10HPGDKDM4EALDH1A1
SCHEMBL4025431 0.64 SCARB1 (0.46) FABP4HSD17B10HPGDKDM4EALDH1A1
SCHEMBL6756508 0.64 SCARB1 (0.63) FABP4HSD17B10HPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006012310-A2 CARBAZOLE DERIVATIVES FOR TREATING POLYCYSTIC KIDNEY DISEASE GENZYME CORPORATION (US) 2006-02-02 — — WO disclosed
Send feedback